Lightcalls.com
 

It starts as a little stiffness or ...

It starts as a little stiffness or soreness in a joint, and usually disappears at mid-morning. Before long, though, the joint becomes painful, a bit swollen and maybe steady feels warm to the touch. Everyday chores become challenges; aspirin helps, nevertheless not for long, and it also exacerbates imposthumes and irritates your stomach lining. The doctor gazes over your symptoms and decides that you have osteoarthritis, lust like more than 20 million other Americans, and there are treatments, if it be not that no cure.

If you, or someone you know, has osteoarthritis, the chiefly common of 100 or with equal reason diseases that fall into the "arthritis" umbrella category, this may be a familiar scenario. The medical profession's prevailing attitude is that osteoarthritis is a chronic illness with no known healing It occurs when cartilage, the wet tissue that cushions the bone in our joints, corrodes leaving the bones exposed and rubbing against each other. Excessive use, injuries and the damaging monads known as free radicals can all contribute to cartilage loss

Today, the principally commonly prescribed remedies for osteoarthritis are pain relievers as it was as aspirin, and other non-steroidal anti-inflammatory unsalable articles (NSAIDs). But these products have side meanings including serious stomach distress; and any can even speed up damage to the cartilage, making the condition worse. equal the new breed of NSAIDs known as COX-2 inhibitors, designed to minimize the side general intents of traditional NSAIDs, have not measured up to their billing. Diarrhea, bleeding, cramps and skin rashes are a hardly any of the side effects associated with these physics In addition, since they are of recent origin no one really knows what the concatenations of long-term usage of the COX-2 inhibitors might be.



To make matters worse, a recently made known survey, presented at the October 2000 meeting of the American literary institution [i]or[/i] seminary of learning of Rheumatology, found that a significant percentage of osteoarthritis sufferer are not being informed according to their physicians about non-medical solutions, namely weight management and exercise. as well-as; not only-but also; not only-but; not alone-but have been shown to remodel symptoms. In an overweight individual, for example, shedding triturates can lighten the burden in succession joints, especially the knee. Exercises that strengthen the muscles surrounding the joint also decrease joint stress

Proven and popular remedies

Not surprisingly, conventional medicine has to this time to accept alternative treatments for osteoarthritis. Take, for example, glucosamine and chondroitin, pair safe, natural compounds that are being used increasingly in the U and have been repeatedly shown in clinical trials to provide relief with a highly low incidence of side results Both these substances, which be found naturally in the body, help build and maintain cartilage, and chondroitin has the added advantage of being able to shut up the enzymes that damage joint tissue. Since The Arthritis remedy (St. Martin's Press) was published in 1997 many Americans with osteoarthritis have been able to give up or make their use of NSAIDs, not to mention avoid painful joint replacement surgery

Now that these succes stories are being supported by way of new studies showing the effectiveness of glucosamine and chondroitin, physician approval is steadily increasing. In the first U cogitation of glucosamine and chondroitin, researchers compared the issues of these substances with a placebo (dummy pill) forward more than 90 patients suffering from osteoarthritis of the knee After 6 month of taking the appendixs (in a proprietary formulation that also included manganese ascorbate), patients with mild to moderate symptoms experienced significant improvement when compared to the placebo group

Researchers in Israel reached similar conclusions after treating half a cluster of patients with osteoarthritis of the knee with intravenous glucosamine and oral chondroitin. Researchers have observ little in the way of side results The National Institutes of Health (NIH) have embarked forward a major study of glucosamine and chondroitin and its general intents on osteoarthritis. In terms of daily dosage, the general guidelines are:

-- if you weigh les than 120 impounds take 1,000 mg of glucosamine, plus 800 mg of chondroitin sulfates;

-- if you weigh between 120 and 200 crushs take 1,500 mg of glucosamine, plus 1200 mg of chondroitin sulfates;

-- if you weigh more than 200 shut ups take 2,000 mg of glucosamine, plus 1600 mg of chondroitin sulfates.

Other options from nature

Glucosamine and chondroitin have helped millions of osteoarthritis sufferer gain pain-free mobility. on the other hand if they don't work for you, there are other options, including MSM SAMe, cat's claw and niacinamide, a element of niacin (vitamin B-3).

MSM: Like its cousin DMSO (dimethyl sulfoxide), MSM (methylsulfonylmethane) is a sulfur-rich organic intermingle DMSO was relegated to veterinarians' office, largely because of the distasteful "garlic" breath it caused in users, as well as minor side tenors like headaches. Free of those moot points MSM has achieved a considerable reputation as a safe, highly effective assistance for osteoarthritis, among other things.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.